IBOK
CRSP icon

Independence Bank of Kentucky’s CRISPR Therapeutics CRSP Stock Holding History

Independence Bank of Kentucky’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.91K Hold
90
– – ﹤0.01% 533
2026
Q1 		$4.28K Hold
90
– – ﹤0.01% 566
2025
Q4 		$4.72K Hold
90
– – ﹤0.01% 588
2025
Q3 		$5.83K Buy
+90
New +$5.17K ﹤0.01% 572

Other funds holding CRSP

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Independence Bank of Kentucky's CRSP Position: Q2 2026 in Review

Independence Bank of Kentucky held its CRISPR Therapeutics (CRSP) position steady in Q2 2026 at 90 shares worth $4.91K. The position accounts for ﹤0.01% of the portfolio, ranked #533.

Independence Bank of Kentucky first reported a position in CRSP in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.83K in Q3 2025. 167 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Independence Bank of Kentucky held 90 shares of CRISPR Therapeutics worth $4.91K as of Q2 2026.
  • Independence Bank of Kentucky left its CRISPR Therapeutics share count unchanged in Q2 2026.
  • CRISPR Therapeutics made up ﹤0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #533 holding.
  • Independence Bank of Kentucky first reported a position in CRISPR Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Independence Bank of Kentucky's CRISPR Therapeutics position peaked at $5.83K in Q3 2025.
  • 167 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.